OP
MNTA

Omni Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Omni Partners’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,561,837
Closed -$82M – 266
2020
Q3 		$82M Buy
+1,561,837
New +$64.7M 5.84% 6

Omni Partners's MNTA Position: Q4 2020 in Review

Omni Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,561,837 shares — an estimated $82M sold.

Omni Partners first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $82M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Omni Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Omni Partners sold 1,561,837 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $82M.
  • Omni Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Omni Partners's Momenta Pharmaceuticals, Inc. position peaked at $82M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Omni Partners's 13F filing for Q4 2020, filed 16 Feb 2021.